Lagos: A new study has revealed that the Gates Foundation‘s bold $2.5 billion investment in women’s health research and development (R&D) could be a game-changer, closing the gender health gap and potentially unlocking $1 trillion in annual global economic growth by 2040.
The funding, which extends through 2030, is aimed at accelerating innovation in maternal, menstrual, gynaecological, and sexual health, with a strong focus on women in low- and middle-income countries.
McKinsey Health Institute (MNI) reports that closing the gender health gap can have a profound ripple effect across economies by increasing workforce participation, leading to better health outcomes, and improved concentration, energy levels, and job performance.
Preventive care and innovation are said to lower the burden on public health systems, leading to improved maternal and child health, and spurring new technologies, treatments, and services.
The initiative will support over 40 innovations across five key areas that have long suffered from chronic underfunding, including obstetric care, contraceptive technologies, STI prevention, and maternal nutrition.
Despite the widespread impact of female-specific health conditions, investment in women’s health R&D remains alarmingly low. A 2021 McKinsey & Company report found that only 1% of healthcare research is dedicated to female-specific conditions outside of cancer.
Common yet debilitating issues such as preeclampsia, gestational diabetes, endometriosis, and menopause continue to be under-researched and poorly understood.
“For too long, women have suffered from health conditions that are misunderstood, misdiagnosed, or ignored,” said Dr Anita Zaidi, President of the Gates Foundation’s Gender Equality Division.
“We want this investment to spark a new era of women-centred innovation—one where women’s lives, bodies, and voices are prioritised.”
Bill Gates, Chair of the Foundation, echoed the urgency of the initiative:
“Investing in women’s health leads to healthier families, stronger economies, and a more just world. Yet it continues to be ignored, underfunded, and sidelined.”
To bridge the persistent funding gap, the foundation is urging governments, philanthropists, investors, and the private sector to co-invest in women’s health solutions, shape product development, and ensure equitable access to treatments for those who need them most.
The five priority areas were chosen based on data, evidence, and direct feedback from women in underserved communities, where misdiagnosis and limited medical training often exacerbate health challenges.
Prof. Bosede Afolabi, Professor of Obstetrics and Gynaecology at the University of Lagos, praised the initiative: “We see the consequences of underinvestment in women’s health every day.
This commitment brings much-needed attention to the health challenges women face in places where resources are most limited and the burden is highest.”
Beyond the health benefits, the economic impact is striking. Research shows that every $1 invested in women’s health yields $3 in financial returns.
This R&D initiative complements the Gates Foundation’s broader efforts in scaling up access to women’s health commodities, including HPV vaccines and child health programs, marking a transformative step toward a healthier, more equitable future for women worldwide.
Nigeria addresses the women’s health gap in its efforts to reduce maternal mortality through expanded access to prenatal care and skilled birth attendants.
It also partners with Non-Governmental Organisations (NGOs) to combat anaemia and improve reproductive health education; however, it still faces challenges in rural healthcare access and gender-based disparities.